LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic BiomarKers in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT04703153 · UNKNOWN
Trial details
- NCT number
- NCT04703153
- Sponsor
- Lucence Health Inc.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-05
- Primary completion
- 2022-12-31
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.